Sign Up to like & get
recommendations!
2
Published in 2022 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics14010150
Abstract: Immune checkpoint inhibitors (ICIs) block checkpoint receptors that tumours use for immune evasion, allowing immune cells to target and destroy cancer cells. Despite rapid advancements in immunotherapy, durable response rates to ICIs remains low. To…
read more here.
Keywords:
situ vaccine;
alf mnota;
therapy;
mnota gzp ... See more keywords